Zacks Research Has Pessimistic View of COO FY2026 Earnings

The Cooper Companies, Inc. (NASDAQ:COO) – Investment analysts at Zacks Research cut their FY2026 earnings per share estimates for Cooper Companies in a research note issued on Tuesday, September 29th. Zacks Research analyst Team now expects that the medical device company will earn $4.53 per share for the year, down from their prior estimate of $4.61. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Cooper Companies’ current full-year earnings is $4.53 per share. Zacks Research also issued estimates for Cooper Companies’ Q4 2026 earnings at $1.07 EPS, Q1 2027 earnings at $1.10 EPS, Q2 2027 earnings at $1.17 EPS, Q3 2027 earnings at $1.18 EPS, Q4 2027 earnings at $1.25 EPS, FY2027 earnings at $4.70 EPS, Q1 2028 earnings at $1.23 EPS, Q2 2028 earnings at $1.28 EPS, Q3 2028 earnings at $1.29 EPS and FY2028 earnings at $5.19 EPS.

A number of other brokerages also recently issued reports on COO. UBS Group lowered their price target on Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a report on Thursday, September 10th. Weiss Ratings raised shares of Cooper Companies from a “sell (d)” rating to a “hold (c-)” rating in a report on Friday, September 18th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $71.00 to $58.00 and set a “neutral” rating for the company in a research report on Thursday, September 10th. Piper Sandler downgraded shares of Cooper Companies from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $86.00 to $59.00 in a research report on Thursday, September 10th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Five research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $71.47.

Cooper Companies Trading Up 1.6%

NASDAQ COO opened at $57.41 on Friday. Cooper Companies has a 12 month low of $51.01 and a 12 month high of $89.83. The stock’s fifty day moving average price is $67.22 and its 200-day moving average price is $67.27. The stock has a market cap of $10.92 billion, a P/E ratio of 19.59, a P/E/G ratio of 2.30 and a beta of 0.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period last year, the business earned $0.49 EPS. Cooper Companies’s quarterly revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Envestnet Portfolio Solutions Inc. lifted its position in shares of Cooper Companies by 112.8% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 15,784 shares of the medical device company’s stock valued at $1,132,000 after buying an additional 8,366 shares during the last quarter. HBK Investments L P acquired a new stake in Cooper Companies in the 2nd quarter worth approximately $31,666,000. Sequoia Financial Advisors LLC grew its position in Cooper Companies by 290.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 34,286 shares of the medical device company’s stock worth $2,459,000 after purchasing an additional 25,504 shares during the last quarter. Tidal Investments LLC increased its stake in Cooper Companies by 281.4% during the 2nd quarter. Tidal Investments LLC now owns 82,903 shares of the medical device company’s stock valued at $5,945,000 after purchasing an additional 61,165 shares in the last quarter. Finally, National Pension Service raised its stake in Cooper Companies by 9,314.0% in the 2nd quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock worth $37,730,000 after acquiring an additional 520,560 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director Lawrence Kurzius purchased 10,000 shares of the stock in a transaction that occurred on Wednesday, September 16th. The stock was purchased at an average price of $54.93 per share, for a total transaction of $549,300.00. Following the completion of the acquisition, the director owned 31,099 shares of the company’s stock, valued at approximately $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of the business’s stock in a transaction dated Monday, September 14th. The shares were purchased at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the purchase, the director owned 20,000 shares of the company’s stock, valued at approximately $1,085,800. This trade represents a 17.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 34,701 shares of company stock valued at $1,880,039 in the last ninety days. 2.08% of the stock is owned by company insiders.

Cooper Companies declared that its Board of Directors has authorized a stock buyback program on Wednesday, September 9th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the medical device company to buy up to 22.7% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Neutral Sentiment: There is no clearly positive company-specific announcement in the latest reports. Investors may be treating the recent decline as an opportunity to buy after concerns about inventory and earnings growth were already reflected in the stock.

About Cooper Companies

CooperCompanies (NASDAQ: COO) is a global medical device company focused on improving vision and advancing women’s health. Its operations are organized primarily through CooperVision and CooperSurgical, which develop, manufacture and distribute products for eye care, fertility and other areas of reproductive health.

CooperVision offers a broad range of contact lenses, including lenses for nearsightedness, farsightedness, astigmatism and presbyopia. Its portfolio includes daily disposable, reusable and specialty lenses, as well as products designed to address the progression of myopia in children and adolescents.